Are aDAM33 polymorphisms associated with asthma susceptibility in a Japanese population?
Our results confirm the involvement of ADAM33 in the development of childhood asthma among the Japanese.
Results showed that telmisartan negatively affected bones suggesting that caution should be taken in possible therapeutic applications for protecting bone health in hypertensive conditions. More studies are necessary to clarify the mechanisms through which telmisartan favors bone loss in this model.